The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis

Abstract

Higher testosterone and lower LH, FSH and prolactin levels were good prognostic factors for patients with metastatic prostatic cancer under hormonal treatment, irrespective of tumour grading.